DPP4 and COVID-19: The mentioned effects of DPP-4 inhibitors are expected to be beneficial for some or even all SARS-CoV-2–infected patients, and we propose them as potential adjunctive treatment option aimed to alleviate COVID-19 long-term complications, especially knowing that millions of people will likely be affected by COVID-19.